Hui Dong

dalian medical university

H指数:19

被引数:1,027

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transformer-Based Multimodal Fusion Integrating Computed Tomography, Pathology, and Clinical Features for Oral Squamous Cell Carcinoma Recurrence Prediction

基于Transformer的多模态融合集成计算机断层扫描、病理学和临床特征用于口腔鳞状细胞癌复发预测

International Dental Journal

IF3.7

2026-09-180

OAAI

Effect of fibrinogen like protein 1 on cisplatin-resistance in laryngeal carcinoma through targeting integrinβ1 in vivo and in vitro

纤维蛋白原样蛋白1通过靶向整合素β1在体内和体外对喉癌顺铂耐药性的影响

Discover Oncology

IF2.9

2025-10-310

Value Analysis of Preoperative Peripheral Blood Markers in the Identification of Benign From Malignant Parotid Gland Tumors

术前外周血标志物在鉴别良性腮腺肿瘤与恶性腮腺肿瘤中的价值分析

International Dental Journal

IF3.7

2025-06-130

Balance of Gata3 and Ramp2 in hepatocytes regulates hepatic vascular reconstitution in postoperative liver regeneration

JOURNAL OF HEPATOLOGY

IF33

2024-02-011

PRE

Combination therapy with oncolytic viruses and immune checkpoint inhibitors in head and neck squamous cell carcinomas: an approach of complementary advantages

CANCER CELL INTERNATIONAL

IF6

2023-01-0516

OAAI

Risk factors and predictive nomograms for early death of patients with pancreatic cancer liver metastasis: A large cohort study based on the SEER database and Chinese population

FRONTIERS IN ONCOLOGY

IF3.3

2022-09-233

OAAI

Expression and prognosis analysis of PAQR5 in kidney cancer

FRONTIERS IN ONCOLOGY

IF3.3

2022-08-314

OAAI

Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer

CELLULAR ONCOLOGY

IF4.8

2022-08-2937

PRE

Case Report: Heterogeneity of Resistance Mechanisms in Different Lesions Co-Mediate Acquired Resistance to First-Line Icotinib in EGFR Mutant Non-Small Cell Lung Cancer

FRONTIERS IN MEDICINE

IF3

2022-07-072

OAAI

RAD21 Confers Poor Prognosis and Affects Ovarian Cancer Sensitivity to Poly(ADP-Ribose)Polymerase Inhibitors Through DNA Damage Repair

RAD21通过DNA损伤修复导致预后不良并影响卵巢癌对聚 (ADP-核糖) 聚合酶抑制剂的敏感性

FRONTIERS IN ONCOLOGY

IF3.3

2022-07-046

OAAI

LINC01119 negatively regulates osteogenic differentiation of mesenchymal stem cells via the Wnt pathway by targeting FZD4

STEM CELL RESEARCH & THERAPY

IF7.3

2022-01-2912

OAAI

A review on the advances and challenges of immunotherapy for head and neck cancer

CANCER CELL INTERNATIONAL

IF6

2021-07-3139

OAAI

Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer

GENOMICS

IF3

2021-07-0141

OAAI

PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes

FRONTIERS IN ONCOLOGY

IF3.3

2021-07-0124

OAAI

Keratin 80 regulated by miR-206/ETS1 promotes tumor progression via the MEK/ERK pathway in ovarian cancer

JOURNAL OF CANCER

IF3.2

2021-01-0118

OAAI

Application and reflection of genomic scar assays in evaluating the efficacy of platinum salts and PARP inhibitors in cancer therapy

基因组scar检测在评估铂盐和PARP抑制剂在癌症治疗中的应用和思考

LIFE SCIENCES

IF5.1

2020-11-0125

OAAI

The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice model

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2020-09-288

PREAI

Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction

BMC PSYCHIATRY

IF3.6

2019-08-1627

OAAI

Treatment of Hyperoxia-Induced Lung Injury with Lung Mesenchymal Stem Cells in Mice

STEM CELLS INTERNATIONAL

IF3.3

2018-09-2612

OAAI

Altered serum levels of vascular endothelial growth factor in first-episode drug-naive and chronic medicated schizophrenia

首发药物治疗和慢性药物治疗的精神分裂症患者血清血管内皮生长因子水平的改变

PSYCHIATRY RESEARCH

IF3.9

2018-06-0112

PREAI

Hui Dong

个人简介

教育背景

工作经历

荣誉奖项

研究方向